Researchers have recently introduced a significant breakthrough in trauma management with the development of oriented hemostatic composite scaffolds. These innovative materials, detailed in the journal Biofabrication, aim to solve the persistent issues of poor fluid absorption and mechanical instability found in current hemostatic products. By creating a "capillary-driven hemostatic microenvironment," the study provides a promising solution for rapid bleeding control in surgical and emergency settings.

The fabrication process involves an advanced acid-enzymatic extraction of high-purity bovine collagen combined with ion-exchange purified carboxymethyl cellulose calcium (CMC-Ca). Consequently, the team used directional freeze-drying technology to construct aligned microchannels within the scaffold. These oriented structures mimic natural capillaries, which significantly accelerates blood infiltration and promotes faster clot formation. Specifically, the purity of the bovine collagen reached 95.7%, ensuring high biocompatibility and minimal adverse reactions.

Clinical Advantages of Hemostatic Composite Scaffolds

The primary benefit of these hemostatic composite scaffolds lies in their structural orientation. Unlike traditional random-pore sponges, the aligned microchannels provide a direct pathway for blood cells and plasma. This design facilitates the rapid concentration of clotting factors at the injury site. Furthermore, the enhanced calcium content in the CMC-Ca component acts as a potent trigger for the coagulation cascade, specifically aiding the conversion of prothrombin to thrombin.

In addition to rapid hemostasis, the composite scaffolds demonstrated superior mechanical stability and excellent in vitro hemocompatibility. Tests showed significantly low hemolysis rates, suggesting that the material is safe for direct contact with human blood. Therefore, this technology could represent a major step forward for surgeons managing complex hemorrhage or traumatic injuries where traditional gauzes often fail to provide adequate control.

Frequently Asked Questions

How does the capillary-driven mechanism improve clotting?

The oriented microchannels act like synthetic capillaries, drawing blood into the scaffold's core much faster than traditional porous materials. This rapid absorption concentrates platelets and clotting factors, leading to a quicker "plug" formation.

What are the main components of this new scaffold?

The scaffold consists of high-purity collagen extracted from bovine hide and carboxymethyl cellulose calcium (CMC-Ca). The CMC-Ca is specifically processed to increase calcium ion content, which further accelerates the body's natural clotting process.

Is this scaffold safe for surgical use?

Yes, the study indicates excellent hemocompatibility and very low hemolysis rates. Its mechanical stability also ensures that the material does not disintegrate easily during the surgical procedure, making it a reliable tool for surgeons.

Disclaimer: This content is for informational and educational purposes only. It does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.

References

1. Zhao H et al. Capillary-Driven Hemostatic Microenvironment in Oriented Collagen / CMC-Ca Composite Scaffold for Rapid Hemostasis. Biofabrication. 2026 Feb 20. doi: 10.1088/1758-5090/ae4894. PMID: 41719586.

2. D'Amico E, et al. Hemostatic Collagen Sponge with High Porosity Promotes the Proliferation and Adhesion of Fibroblasts and Osteoblasts. Molecules. 2023;24(9):7749.

3. Khoshmohabat H, et al. A review of the application of cellulose hemostatic agent on trauma injuries. Trauma Mon. 2019;24(4):e68257.